Pharmaceutical Executive May 16, 2022
Pharmaceutical Executive Editorial Staff

The second of two parts of Pharmaceutical Executive’s Q&A discussion with Vinod Badami, Vice President, Data and Analytics at Indegene.

Pharmaceutical Executive: Does social listening provide real-world evidence (RWE) for drug development?

Vinod Badami: As mentioned earlier, HCPs are starting to get more comfortable with discussing medical-related information on social media. They evaluate the safety and efficacy of treatments through debates and discussions, promote new drug discoveries, and so on.

Similarly, patients have also taken to online review platforms or discussion forums to share their personal experiences, challenges, and side effects using specific treatments.

As a result, there is massive amount of information (albeit unstructured) that pharmaceutical organizations can leverage in addition to the structured RWE sources (like claims...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Big Data, Interview / Q&A, Social Media, Technology, Trends
Walking the TikTok Tightrope: Social Media Use by Healthcare Professionals
Opinion: Kids can’t wait any longer for social media safety
The next global tech chokepoints
Tech solutions to kids’ mental health woes
Social Media Study Reveals Pervasive HIV Vaccine Conspiracy Theories

Share This Article